Seattle-area company Helion Energy gets $425 million from investors including Sam Altman and Softbank to pursue clean energy's "Holy Grail."
OpenAI CEO Sam Altman posted a picture of himself with Microsoft CEO Satya Nadella on Tuesday and suggested the two companies are getting along just fine.
OpenAI CEO Sam Altman has publicly applauded competitor DeepSeek’s R1 model in a recent social media post.
Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become a for-profit corporation, and he regularly trolls the company on X—the platform he bought for $44 billion back in 2022. All of which is why the past week has been hilarious.
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's feuded with CEO Sam Altman.
Altman said that a project like Stargate might not have been possible with "a different president."
Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.
OpenAI chief executive Sam Altman has welcomed the debut of DeepSeek’s R1 model and has promised to deliver better AI models. The Chinese artificial intelligence start-up that rocketed to global prominence has delivered an “impressive model, particularly around what they’re able to deliver for the price,” Altman wrote.
Donald Trump and three top tech firms announced on Tuesday that they would create a new company called Stargate to grow artificial intelligence infrastructure in the U.S. The President also said the three companies will collaborate and invest $500 billion in the AI infrastructure project.
The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.
SoftBank, OpenAI, and Oracle are launching a $500 billion joint venture named Stargate to fund AI infrastructure in the U.S. The initiative, praised by President Trump, aims to deploy $100 billion immediately for projects like data centers and cancer research.